<?xml version="1.0"?>

<Studies>

  <Study SID="CCC-501-24" SGender="Female">
     <Name>Treatment of Radiation Firbrosis</Name>
     <Summary>This study is investigating whether two drugs, vitamin E(Alpha-tocopherol),
              and Oxpentifylline, may help to heal body tissues damaged by radiotheraphy.
     </Summary>
     <PI>Richard Tunney</PI>
     <Start_Date>1998-05-01</Start_Date>
     <Stop_Date>2003-06-15</Stop_Date>
     <Enrollment>24</Enrollment>
     <Phase>3</Phase>
     <Site>University Hospital</Site>
  </Study>

  <Study SID="CCC-510-43" SGender="Female">
     <Name>Tamoxifen for Early Stage Breast Cancer</Name>
     <Summary>This study is to discover whether taking tamoxifen for longer than five years
              will reduce the risk of recurrence without additional side effects.
     </Summary>
     <PI>Alice Walters</PI>
     <Start_Date>1999-12-01</Start_Date>
     <Stop_Date>2009-11-30</Stop_Date>
     <Enrollment>100</Enrollment>
     <Phase>3</Phase>
     <Site>University Hospital</Site>
     <Site>St. Thomas Vianney Hospital</Site>
     <Site>Ohio Cancer Clinic</Site>
  </Study>

  <Study SID="CCC-510-48" SGender="Females">
     <Name>Taxoprexin for Advanced Breast Cancer</Name>
     <Summary>This study seeks to dicover the effacy of of Taxoprexin in treating advanced
              stage breast cancer, to determine the side effects of Taxoprexin, and to determine
              how quickly the body gets rid of Taxoprexin.
     </Summary>
     <PI>Chandaskar Rao</PI>
     <Start_Date>2002-04-15</Start_Date>
     <Stop_Date>2003-04-15</Stop_Date>
     <Enrollment>15</Enrollment>
     <Phase>Two</Phase>
     <Site>University Hospital</Site>
   </Study>

   <Study SID="CCC-425-08" SGender="Male">
      <Name>CT Scanning in Early Stage Testicular Cancer</Name>
      <Summary>This study tests whether giving CT scans more often will detect the recurrence
               of testicular cancer earlier.
      </Summary>
      <PI>Dennis Lehman</PI>
      <Start_Date>2002-11-15</Start_Date>
      <Stop_Date>2007-11-14</Stop_Date>
      <Enrollment>48</Enrollment>
      <Phase>3</Phase>
      <Site>University Hospital</Site>
      <Site>Ohio Cancer Clinic</Site>
   </Study>

   <Study SID="CCC-805-88" SGender="All">
      <Name>Chemotheraphy with Cisplatin and Irintecan in Advanced Pancreatic Cancer</Name>
      <Summary>This study test whether giving patients of combination of chemotheraphy with
               cisplatin and irinotecan will control the symptons of advanced pancreatic
               cancer.
      </Summary>
      <PI>Michael Siudzinski</PI>
      <Start_Date>2003-06-01</Start_Date>
      <Stop_Date>2005-05-31</Stop_Date>
      <Enrollment>12</Enrollment>
      <Phase>2</Phase>
      <Site>Unversity Hospital</Site>
   </Study>

   <Study SID="CCC-718-14" SGender="All">
      <Name>Encrecolomab in Post-Surgical Colon Cancer</Name>
      <PI>Linda Sanchez</PI>
      <Start_Date>2003-01-15</Start_Date>
      <Stop_Date>2008-12-31</Stop_Date>
      <Enrollment>1000</Enrollment>
      <Phase>3</Phase>
      <Site>Univeristy Hospital</Site>
      <Site>Ohio Cancer Clinic</Site>
      <Site>St. Thomas Vianney Hospital</Site>
      <Site>Midwest Cancer Center</Site>
      <Site>Methodist Hospital</Site>
   </Study>

   <Study SID="CCC-330-21" SGender="Both">
      <Name>Cisplatin in the Treatment of Mesothelioma</Name>
      <Summary>This study examines the effacy of cisplatin in the treatment of
               mesothelioma using a standard randomized clinical trial.
      </Summary>
      <PI>Karen Cho</PI>
      <Start_Date>2003-04-01</Start_Date>
      <Stop_Date>2008-03-31</Stop_Date>
      <Enrollment>240</Enrollment>
      <Phase>Three</Phase>
      <Site>University Hospital</Site>
      <Site>Ohio Cancer Clinic</Site>
   </Study>
</Studies>